1. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients with family history of breast/ovarian cancer. 2. To evaluate the prevalence of BRCA1/2 mutation of breast cancer patients without family history, but high risk of hereditary cancer. 3. To evaluate the prevalence of BRCA1/2 mutation of family member of BRCA1/2 mutation. 4. To evaluate the prevalence of ovarian cancer of population of above 3 groups.
1. To find founder mutation in Korean 2. To correlation prevalence with risk evaluation 3. To find risk factors concerning life style
Study Type
OBSERVATIONAL
Enrollment
2,250
Department of Surgery, Breast & Endocrine Service Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
RECRUITINGFind out the prevalence of BRCA1/2 mutation of high risk breast cancer patients
Time frame: 6 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.